Literature DB >> 34856844

Social overcrowding impacts gut microbiota, promoting stress, inflammation, and dysglycemia.

Clara Delaroque1, Mélissa Chervy2, Andrew T Gewirtz3, Benoit Chassaing1.   

Abstract

An array of chronic inflammatory diseases, including metabolic diseases such as obesity and diabetes, are thought to be promoted by disturbance of the intestinal microbiota. Such diseases disproportionately impact low-income communities, which are frequently afflicted by chronic stress and increased density housing. Hence, we hypothesized that overcrowded housing might promote stress, microbiota dysbiosis, inflammation, and, consequently, metabolic diseases. We tested this hypothesis in a tractable murine model of social overcrowding (SOC), in which mice were housed at twice normal density. SOC moderately impacted behavior in some widely used assays (Open Field, Elevated Plus Maze and Light/Dark tests) and resulted in a stark increase in corticosterone levels. Such indices of stress were associated with mild chronic gut inflammation, hyperglycemia, elevations in colonic cytokines, and alterations in gut microbiota composition. All of these consequences of SOC were eliminated by broad spectrum antibiotics, while some (inflammation and hyperglycemia) were transmitted by microbiota transplantation from SOC mice to germfree mice housed at normal density. Altogether, these results suggest a central role for intestinal microbiota in driving stress, inflammation, and chronic diseases that are promoted by overcrowded housing.

Entities:  

Keywords:  Social stress; inflammation; metabolic deregulations; microbiota

Mesh:

Substances:

Year:  2021        PMID: 34856844      PMCID: PMC8726700          DOI: 10.1080/19490976.2021.2000275

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  44 in total

Review 1.  [Low-grade systemic inflammation and the development of metabolic diseases: from the molecular evidence to the clinical practice].

Authors:  José Israel León-Pedroza; Luis Alonso González-Tapia; Esteban del Olmo-Gil; Diana Castellanos-Rodríguez; Galileo Escobedo; Antonio González-Chávez
Journal:  Cir Cir       Date:  2015-07-06       Impact factor: 0.361

Review 2.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

3.  Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation.

Authors:  Benoit Chassaing; Tom Van de Wiele; Jana De Bodt; Massimo Marzorati; Andrew T Gewirtz
Journal:  Gut       Date:  2017-03-21       Impact factor: 23.059

4.  Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015.

Authors:  James M Dahlhamer; Emily P Zammitti; Brian W Ward; Anne G Wheaton; Janet B Croft
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-10-28       Impact factor: 17.586

5.  Social overcrowding as a chronic stress model that increases adiposity in mice.

Authors:  En-Ju D Lin; Meng Sun; Eugene Y Choi; Daniel Magee; Colin W Stets; Matthew J During
Journal:  Psychoneuroendocrinology       Date:  2014-10-16       Impact factor: 4.905

6.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms.

Authors:  J Gregory Caporaso; Christian L Lauber; William A Walters; Donna Berg-Lyons; James Huntley; Noah Fierer; Sarah M Owens; Jason Betley; Louise Fraser; Markus Bauer; Niall Gormley; Jack A Gilbert; Geoff Smith; Rob Knight
Journal:  ISME J       Date:  2012-03-08       Impact factor: 10.302

7.  UniFrac--an online tool for comparing microbial community diversity in a phylogenetic context.

Authors:  Catherine Lozupone; Micah Hamady; Rob Knight
Journal:  BMC Bioinformatics       Date:  2006-08-07       Impact factor: 3.169

8.  Relationship between socioeconomic status and type 2 diabetes: results from Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012.

Authors:  Jongnam Hwang; Changwoo Shon
Journal:  BMJ Open       Date:  2014-08-19       Impact factor: 2.692

9.  Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.

Authors:  Hiroko Nagao-Kitamoto; Andrew B Shreiner; Merritt G Gillilland; Sho Kitamoto; Chiharu Ishii; Akiyoshi Hirayama; Peter Kuffa; Mohamad El-Zaatari; Helmut Grasberger; Anna M Seekatz; Peter D R Higgins; Vincent B Young; Shinji Fukuda; John Y Kao; Nobuhiko Kamada
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-03-03

10.  Health Benefits of Lactobacillus gasseri CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Kensei Nishida; Daisuke Sawada; Yuki Kuwano; Hiroki Tanaka; Kazuhito Rokutan
Journal:  Nutrients       Date:  2019-08-10       Impact factor: 5.717

View more
  4 in total

Review 1.  The role of intestinal microbiota and its metabolites in intestinal and extraintestinal organ injury induced by intestinal ischemia reperfusion injury.

Authors:  Fan Deng; Ze-Bin Lin; Qi-Shun Sun; Yue Min; Yue Zhang; Yu Chen; Wen-Ting Chen; Jing-Juan Hu; Ke-Xuan Liu
Journal:  Int J Biol Sci       Date:  2022-06-13       Impact factor: 10.750

2.  Stressor-Induced Reduction in Cognitive Behavior is Associated with Impaired Colonic Mucus Layer Integrity and is Dependent Upon the LPS-Binding Protein Receptor CD14.

Authors:  Robert M Jaggers; Damon J DiSabato; Brett R Loman; Danica Kontic; Kyle D Spencer; Jacob M Allen; Jonathan P Godbout; Ning Quan; Tamar L Gur; Michael T Bailey
Journal:  J Inflamm Res       Date:  2022-03-03

Review 3.  Crosstalk between gut microbiota and renal ischemia/reperfusion injury.

Authors:  Peng Huang; Jianwei Cao; Jingyi Chen; Yanrong Luo; Xiaofang Gong; Chengyi Wu; Yu Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-09-05       Impact factor: 6.073

Review 4.  Obesity and Bone: A Complex Relationship.

Authors:  Giuseppe Rinonapoli; Valerio Pace; Carmelinda Ruggiero; Paolo Ceccarini; Michele Bisaccia; Luigi Meccariello; Auro Caraffa
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.